Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cancer Investigation|March 17, 2007
Results of a phase II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based clinic?William Berry, Maha Elkordy, Mark O'Rourke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancerDavid Loesch, Nicholas Robert, Lina Asmar, et al.The Oncologist|April 24, 2021
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare CancersWilliam Jeffery Edenfield, Ki Chung, Mark O'Rourke, et al.JCO Oncology Practice|July 13, 2021
Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment TrialsJulia Mo, Amy K Darke, Katherine A Guthrie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyFrances A Shepherd, Janet Dancey, Rodryg Ramlau, et al.Clinical Colorectal Cancer|August 24, 2011
A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancerShivaani Kummar, M Sitki Copur, Michal Rose, et al.Clinical Genitourinary Cancer|December 12, 2012
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancerMatthew D Galsky, Noah M Hahn, Thomas Powles, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581Donna Niedzwiecki, Monica M Bertagnolli, Robert S Warren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2022
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, et al.The Lancet. Gastroenterology & Hepatology|August 4, 2023
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trialRobert S Krouse, Garnet L Anderson, Kathryn B Arnold, et al.Pageof 1